Journal article

Efficacy and Safety of Abatacept in Lupus Nephritis A Twelve-Month, Randomized, Double-Blind Study

Richard Furie, Kathy Nicholls, Tien-Tsai Cheng, Frederic Houssiau, Ruben Burgos-Vargas, Shun-Le Chen, Jan L Hillson, Stephanie Meadows-Shropshire, Michael Kinaszczuk, Joan T Merrill

Arthritis & Rheumatology | WILEY | Published : 2014

Grants

Funding Acknowledgements

Supported by Bristol-Myers Squibb.Dr. Furie has received consulting fees from Bristol-Myers Squibb (less than

0,000). Dr. Houssiau has received consulting fees, speaking fees, and/or honoraria from Human Genome Sciences, GlaxoSmithKline, and UCB (less than
0,000 each). Dr. Burgos-Vargas has received consulting fees, speaking fees, and/or honoraria from Abbvie, Bristol-Myers Squibb, Jannsen, Pfizer, Roche, and UCB (less than
0,000 each). Dr. Hillson, Ms. Meadows-Shropshire, and Mr. Kinaszczuk own stock or stock options in Bristol-Myers Squibb. Dr. Merrill has received consulting fees, speaking fees, and/or honoraria from Bristol-Myers Squibb (less than
0,000).